Wells Pharma of Houston LLC recalls Ketamine Hydrochloride Injectable Solution, 50mg/ml, (50 mg per mL) Volume: 1 mL, 5265 Kitty Drive, Houston, TX 77054, NDC…

cGMP deviations.

Date

2026-05-06

Country

United States

Brand

Wells Pharma of Houston

Product

Ketamine Hydrochloride Injectable Solution, 50mg/ml, (50 mg per mL) Volume: 1 mL, 5265 Kitty Drive, Houston, TX 77054, NDC 73702-302-31.

Classification

Class II

Units

U.S. Nationwide.

Category

Drugs & medical

Source

FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

1. Check the product name, strength and lot number against the official notice.
2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Wells Pharma of Houston recalls

1. 2023-12-13
2. US
   Drugs & medicalClass II

   Wells Pharma of Houston LLC recalls ceFAZolin sodium in Sterile Water for injection, Injectable Solution, 1g/10mL (0.1 g per mL), Syringe, Rx only, Wells Pharma, NDC…

   Lack of assurance of sterility.

   FDA · DrugWells Pharma of Houston LLCPhiladelphia, Pennsylvania.Official notice →

Other drugs & medical recalls in the United States

1. 2026-05-06
2. US
   Drugs & medicalClass I

   Boston Scientific Corporation recalls Boston Scientific Cardiac Resynchronization Therapy (CRT)labeled as: 1. VALITUDE CRT-P EL, Model Number U125; 2. VALITUDE CRT-P EL…

   Updated software, Brady software maintenance release 6 (SMR6), is now available for the ACCOLADE" family of pacemakers and cardiac resynchronization therapy pacemakers (CRT-Ps)1 and the advisory population is expanding…

   FDA · DeviceBoston Scientific CorporationworldwideOfficial notice →
3. US
   Drugs & medicalClass II

   Hikma Pharmaceuticals USA INC recalls Alendronate Sodium Oral Solution, 70 mg/75 mL, 75 mL, Rx only, 4 x 75 mL Single Dose Bottles, Distr. by: Hikma Pharmaceuticals USA…

   This recall is being conducted due to out of specification assay results in a limited number of bottles that were stored on side.

   FDA · DrugHikma Pharmaceuticals USA INCUS Nationwide.Official notice →
4. US
   Drugs & medicalClass III

   Water-Jel Technologies, LLC recalls Lidocaine Wound Gel (Benzalkonium Chloride, 0.13% and Lidocaine Hydrochloride, 2%), NET WT 0.5 OZ (14 g), Distributed by: CVS…

   Failed PH Specifications

   FDA · DrugWater-Jel Technologies, LLCNationwide in the USAOfficial notice →
5. US
   Drugs & medicalClass II

   Thea Pharma, Inc. recalls Similasan, iVIZIA, Sterile Lubricant Eye Drops (Povidone 0.5%), 0.33 Fl oz (10 mL), Made in France, Distributed by: Thea Pharma Inc.,…

   Lack of Assurance of Sterility: This recall has been initiated due to CGMP deviations found by the FDA during an inspection of the manufacturer.

   FDA · DrugThea Pharma, Inc.Nationwide within the United StatesOfficial notice →
6. US
   Drugs & medicalClass II

   SCOPE HEALTH recalls Optase Dry Eye Intense Drops (Glycerin 0.2%), packaged in 0.33 fl oz, Sterile, Manufactured for Scope Health Inc., 79 Madison Ave., 8th…

   Lack of Assurance of Sterility

   FDA · DrugSCOPE HEALTHNationwide within the United StatesOfficial notice →
7. US
   Drugs & medicalClass III

   American Regent, Inc. recalls Levocarnitine Injection, USP, 1 g/5 mL (200 mg/mL), 5 mL Single-Dose Vial, For intravenous use, Rx Only, American Regent, Inc., Shirley,…

   Labeling: Missing Label

   FDA · DrugAmerican Regent, Inc.U.S. NationwideOfficial notice →